NCT04744961

Brief Summary

This study involves surveying two matched groups of patients that underwent dermatologic surgery at our department. One group had a documented surgical site infection and the other didn't. All patients will be asked to complete a questionnaire in which they assess the physical appearance of their scars and its psychosocial impact. Results will be compared between the groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 3, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 9, 2021

Completed
15 days until next milestone

Study Start

First participant enrolled

February 24, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 17, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 17, 2021

Completed
Last Updated

May 18, 2021

Status Verified

May 1, 2021

Enrollment Period

3 months

First QC Date

February 3, 2021

Last Update Submit

May 17, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparing mean values of SCAR-Q scores in both groups

    Scar-Q (http://qportfolio.org/scar-q/) is a patient reported outcome instrument in which scars will be assessed in terms of scar appearance and psychosocial impact. Scores will range from 0 (worst) to 100 (best). Scores will be compared between the two groups using either parametric or non-parametric tests depending on the distribution of the results.

    3 months

Secondary Outcomes (1)

  • Association between patient characteristics and SCAR-Q scores

    3 months

Study Arms (2)

Surgical site infections

Other: SCAR-Q survey

Normal would healing

Other: SCAR-Q survey

Interventions

Telephone survey

Normal would healingSurgical site infections

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All included patients had a surgical procedure performed at our department. One group had documented surgical site infections and the other didn't.

You may qualify if:

  • Patient above 18 years of age that underwent a dermatosurgical procedure at our department between march 2017 and march 2020.

You may not qualify if:

  • Patients assessed as not suitable for telephone survey due to hearing disabilities or cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of dermatology, Skåne university hospital

Lund, 22185, Sweden

Location

MeSH Terms

Conditions

Surgical Wound InfectionPatient Satisfaction

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, M.D, Ph.D

Study Record Dates

First Submitted

February 3, 2021

First Posted

February 9, 2021

Study Start

February 24, 2021

Primary Completion

May 17, 2021

Study Completion

May 17, 2021

Last Updated

May 18, 2021

Record last verified: 2021-05

Locations